Opiranserin (VVZ-149) hydrochloride, a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 µM, respectively. Opiranserin hydrochloride shows antagonistic activity on rP2X3 (IC50=0.87 µM). Opiranserin hydrochloride is development as an injectable agent for the treatment of postoperative pain[1][2][3].
Molecular Weight:
430.97
Purity:
99.62
CAS Number:
[1440796-75-7]
Formula:
C21H35ClN2O5
Target:
5-HT Receptor,GlyT,P2X Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted